This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis.
The Journal of clinical endocrinology and metabolism, 103(8), 2949-2957
Citation
Bone, Henry G; Cosman, Felicia; Miller, Paul D; Williams, Gregory C; Hattersley, Gary; Hu, Ming-Yi; Fitzpatrick, Lorraine A; Mitlak, Bruce; Papapoulos, Socrates; Rizzoli, René; Dore, Robin K; Bilezikian, John P; Saag, Kenneth G. (2018). ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis.. The Journal of clinical endocrinology and metabolism, 103(8), 2949-2957. https://doi.org/10.1210/jc.2018-00163